deferasirox
- Product NDC
- 70710-1276
- 11-digit product format
- 707101276
- Labeler code
- 70710
- Product ID
- 70710-1276_b011a8f6-9341-4dfb-a7cf-eb30cdae32d2
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- deferasirox
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Application
- ANDA211383
- Marketing category
- ANDA
- Marketing start
- 2020-06-16
- Substance
- DEFERASIROX
- Active strength
- 180 mg/1
- Pharmacologic classes
- Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| V8G4MOF2V9 | DEFERASIROX | 201530-41-8 | DEFERASIROX |
Packages
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 70710-1276-1 | 70710127601 | 100 TABLET, FILM COATED in 1 BOTTLE (70710-1276-1) | 2020-06-16 | No | No | Historical |
| 70710-1276-3 | 70710127603 | 30 TABLET, FILM COATED in 1 BOTTLE (70710-1276-3) | 2020-06-16 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| deferasirox | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited | 2023-07-24 | HUMAN PRESCRIPTION DRUG LABEL | 12 |